Canale-Theakston Carin 4
4 · Cidara Therapeutics, Inc. · Filed Dec 19, 2024
Insider Transaction Report
Form 4
Canale-Theakston Carin
Director
Transactions
- Award
Stock Option (right to buy)
2024-12-17+16,000→ 16,000 totalExercise: $22.81Exp: 2034-12-16→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of December 17, 2024.